We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.86B
AUM Growth
+$344M
Cap. Flow
+$315M
Cap. Flow %
11.01%
Top 10 Hldgs %
23.55%
Holding
1,809
New
745
Increased
318
Reduced
227
Closed
516

Sector Composition

Rank Sector Weight
1 Utilities 15.61%
2 Technology 12.98%
3 Industrials 12.91%
4 Consumer Discretionary 9.54%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNGA
1251
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$84K ﹤0.01%
14,500
-130,913
-90% -$787K
ZG icon
1252
Zillow
ZG
$8.27B
$82K ﹤0.01%
+2,778
New +$110K
OPTN
1253
DELISTED
OptiNose
OPTN
$77K ﹤0.01%
+733
New +$73.2K
SMSI icon
1254
Smith Micro Software
SMSI
$16.7M
$77K ﹤0.01%
+353
New +$72.5K
NPTN
1255
DELISTED
NEOPHOTONICS CORP
NPTN
$77K ﹤0.01%
+12,700
New +$71.4K
SIGA icon
1256
SIGA Technologies
SIGA
$218M
$74K ﹤0.01%
+14,454
New +$78K
RDS.B
1257
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$73K ﹤0.01%
+1,222
New +$72.9K
HCR
1258
DELISTED
Hi-Crush Inc. Common Stock
HCR
$72K ﹤0.01%
41,100
+29,600
+257% +$56.9K
LUNA
1259
DELISTED
Luna Innovations Incorporated
LUNA
$70K ﹤0.01%
+12,100
New +$66.9K
HROW icon
1260
Harrow
HROW
$1.54B
$69K ﹤0.01%
+12,200
New +$79.9K
VBIV
1261
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$68K ﹤0.01%
+4,830
New +$101K
ROX
1262
DELISTED
Castle Brands, Inc.
ROX
$68K ﹤0.01%
+54,200
New +$43.8K
ONCT
1263
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$66K ﹤0.01%
+660
New +$67.6K
MYOV
1264
DELISTED
Myovant Sciences Ltd.
MYOV
$66K ﹤0.01%
+12,600
New +$93.5K
SXC icon
1265
SunCoke Energy
SXC
$822M
$65K ﹤0.01%
+11,509
New +$82.9K
FSK icon
1266
FS KKR Capital
FSK
$3.29B
$64K ﹤0.01%
+2,739
New +$64.2K
XCUR icon
1267
Exicure
XCUR
$7.53M
$64K ﹤0.01%
+168
New +$64.2K
HIL
1268
DELISTED
Hill International, Inc. Common Stock
HIL
$64K ﹤0.01%
+21,500
New +$62.7K
ABUS icon
1269
Arbutus Biopharma
ABUS
$1.03B
$61K ﹤0.01%
+39,700
New +$68.4K
UTI icon
1270
Universal Technical Institute
UTI
$1.23B
$59K ﹤0.01%
+10,900
New +$48.2K
MGI
1271
DELISTED
MoneyGram International, Inc. New
MGI
$59K ﹤0.01%
+14,800
New +$51.8K
BW icon
1272
Babcock & Wilcox
BW
$1.23B
$58K ﹤0.01%
+12,100
New +$46.3K
SAND
1273
DELISTED
Sandstorm Gold
SAND
$57K ﹤0.01%
+10,174
New +$61.9K
ADBE icon
1274
Adobe
ADBE
$109B
$55K ﹤0.01%
200
-21,958
-99% -$6.41M
SNDA icon
1275
Sonida Senior Living
SNDA
$1.9B
$55K ﹤0.01%
833
-52
-6% -$3.64K

Similar funds

Michael Gelband's Q3 2019 Portfolio in Review

As of Q3 2019, Michael Gelband held 1,809 positions worth $2.86B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Michael Gelband deployed $315M of net new capital in Q3 2019, opening 745 new positions and adding to 318 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.

By sector, the portfolio is most concentrated in Utilities at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $41.1M trimmed.

  • Michael Gelband's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 324,777 shares worth $38.7M.
  • Michael Gelband added most to Aramark in Q3 2019, an estimated $65.8M increase.
  • Michael Gelband's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $41.1M.
  • Michael Gelband fully exited Altaba Inc in Q3 2019, selling an estimated $68.3M.
  • Michael Gelband's ten largest holdings make up 24% of its $2.86B portfolio in Q3 2019.
  • Michael Gelband opened 745 new positions and closed 516 in Q3 2019.
  • Michael Gelband's portfolio value rose 14% quarter-over-quarter to $2.86B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.